Dyne therapeutics stock

WebThe latest price target for . Dyne Therapeutics (NASDAQ: DYN) was reported by Chardan Capital on March 3, 2024.The analyst firm set a price target for $20.00 expecting DYN to rise to within 12 ... WebHere's Why Dyne Therapeutics, Inc. (DYN) Is a Great 'Buy the Bottom' Stock Now Zacks - Fri Dec 9, 2024 . Dyne Therapeutics, Inc. (DYN) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement...

Investors & Media Dyne Therapeutics, Inc.

WebComplete Dyne Therapeutics Inc. stock information by Barron's. View real-time DYN stock price and news, along with industry-best analysis. WebApr 11, 2024 · Dyne Therapeutics Stock Performance. NASDAQ DYN opened at $8.82 on Tuesday. The stock has a market cap of $496.90 million, a price-to-earnings ratio of -2.72 and a beta of 0.24. The business has a ... dgl.heterograph metapath https://movementtimetable.com

Dyne Therapeutics, Inc. (NASDAQ:DYN) Receives Consensus …

WebMar 29, 2024 · Here's Why Dyne Therapeutics, Inc. (DYN) Is a Great 'Buy the Bottom' Stock Now. Dyne Therapeutics, Inc. (DYN) appears to have found support after losing … WebSep 6, 2024 · Dyne Therapeutics is a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases. With its proprietary FORCE™ platform, Dyne is developing modern oligonucleotide therapeutics that are designed to overcome limitations in delivery to … WebApr 11, 2024 · Let’s start up with the current stock price of Dyne Therapeutics Inc. (DYN), which is $8.82 to be very precise. The Stock rose vividly during the last session to $9.35 after opening rate of $9.34 while the lowest price it went was recorded $8.77 before closing at $9.38.Recently in News on March 23, 2024, Dyne Therapeutics Receives FDA … dglheterograph\\u0027 object has no attribute cuda

Should You Add Dyne Therapeutics Inc (DYN) Stock to Your …

Category:Dyne Therapeutics, Inc. (DYN) Stock Price, News, Quote

Tags:Dyne therapeutics stock

Dyne therapeutics stock

Dyne Therapeutics (DYN) Stock Price & Analysis - TipRanks

WebARF Manager. Genocea Biosciences. Sep 2024 - Feb 20243 years 6 months. Cambridge, MA. WebStock analysis for Dyne Therapeutics Inc (DYN:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

Dyne therapeutics stock

Did you know?

WebMar 20, 2024 · positioned for growth. Dyne Therapeutics is a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people … WebApr 11, 2024 · Dyne Therapeutics Trading Down 6.0 %. DYN stock opened at $8.82 on Tuesday. The firm has a 50 day moving average of $12.59 and a 200-day moving average of $12.09. The firm has a market ...

WebGet the latest Dyne Therapeutics Inc (DYN) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and … WebApr 7, 2024 · What is Dyne Therapeutics Inc Ordinary Shares’s stock style? DYN’s stock style is Small Value. Style is an investment factor that has a meaningful impact on …

WebApr 11, 2024 · Let’s start up with the current stock price of Dyne Therapeutics Inc. (DYN), which is $8.82 to be very precise. The Stock rose vividly during the last session to $9.35 … WebDyne Therapeutics to Present at Upcoming Investor Conferences. WALTHAM, Mass., March 07, 2024 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases, today announced that …

WebOct 4, 2024 · Dyne Therapeutics (Nasdaq: DYN), a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with …

WebDec 31, 2024 · Dyne Therapeutics. (DYN) is scheduled to report earnings on March 9, 2024.The last reported earnings were for reported on November 3, 2024 for Q3. dglheterograph\u0027 object has no attribute cudaWebThe Dyne Therapeutics stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, … cibolo creek boerneWebView the latest Dyne Therapeutics Inc. (DYN) stock price, news, historical charts, analyst ratings and financial information from WSJ. cibolo creek vineyards llcWebFeb 27, 2024 · The 86 rating InvestorsObserver gives to Dyne Therapeutics Inc stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 99 percent of stocks in the Biotechnology industry, DYN’s 86 overall rating means the stock scores better than 86 percent of all stocks. dglgraph\\u0027 object has no attribute is_blockWebApr 11, 2024 · Dyne Therapeutics Stock Performance. NASDAQ DYN opened at $8.82 on Tuesday. The stock has a market cap of $496.90 million, a price-to-earnings ratio of -2.72 and a beta of 0.24. The business has a 50 day simple moving average of $12.59 and a 200 day simple moving average of $12.09. Dyne Therapeutics has a 52-week low of $4.30 … dglheterograph\\u0027 object has no attribute clearWebApr 10, 2024 · 5 brokerages have issued twelve-month target prices for Dyne Therapeutics' shares. Their DYN share price forecasts range from $18.00 to $34.00. On average, they … cibolo energy operatingWebDYN stock forecast Our latest prediction for Dyne Therapeutics Inc's stock price was made on the Dec. 15, 2024 when the stock price was at 13.59$.. In the short term (2weeks), DYN's stock price should underperform the market by -4.52%.During that period the price should oscillate between -12.37% and +6.64%.. In the medium term (3months), DYN's … dgl golf livescoring